Sikes and French, Ltd., two National Priority List sites that are proximal to one another, are located approximately 20 mi (32 km) east of Houston, Texas. Dumping at Sikes occurred during the early 1960s and continued until 1967. Benzene, 1,2-dichloroethane, toluene, 1,1,2-trichloroethane, naphthalene, lead, fluorene, and pyrene are chemicals that pose a particular public health concern. French, Ltd., commenced operations in 1966, and dumping ceased in 1973. Chemicals of potential public health impact at the French, Ltd., site are benzene, benzo(a)anthracene, benzo(a)pyrene, copper, chrysene, chromium, dichlorodiphenyltrichloroethane, heptachlor, lead, nickel, polychlorinated biphenyls, tetrachloroethylene, trichloroethylene, and zinc. During the 1980s, both sites were placed on the National Priority List. Barrett Station is a stable black community located near the two sites. The question of whether levels of exposure to dumpsite chemicals were related to health complaints in the Barrett Station population was examined. The prevalence of 29 symptoms reported by 321 individuals who had been highly exposed was compared with symptoms reported by a group of 351 persons from the same community who had limited exposure. A meaningful difference between the two groups emerged for some of the symptoms, the most notable of which symptoms were neurologic. Almost twice as many subjects in the high-exposure group reported five or more neurologic symptoms, compared with the low-exposure group. This excess of neurological symptoms is consistent with the known toxic properties of the chemicals at the sites.

Review Article IJOAR (2020) 3:68 Smokeless Tobacco dependence and cessation measures in India India being the largest smokeless tobacco (SLT) producer and consumer in the South East Asia Region (SEAR) entitled with a range of products. SLT consumption is very common because it is associated with socioeconomic and cultural perspectives in the India. After the implementation of the first treaty of the World Health Organization Framework Convention on Tobacco Control (WHO-FCTC), public health standards were reaffirmed and improvised through successful implementation of articles since 2007 as reported in the global progress factsheet. Many measures have been implemented for achieving the success of WHO-FCTC in India and to control the huge disease burden induced by tobacco use. The objective of the present study was to understand and explore the factors involved in the SLT demand reduction by revealing the dependence and cessation implementation in India in the context of strategies and policies. For this study, we searched for SLT dependence and SLT cessation literature survey in PubMed and obtained 102 literatures consisting of studies and reviews, which were further scrutinized by excluding the reviews, studies conducted abroad and studies conducted within the last 5 years (after 2015). No statistical significance was observed in comparison of National to International SLT dependence and an attempt to quit SLT following the tenure of a year. This is in-line with GATS-2 and international data. We have also discussed a diverse approach in the control of SLT at different levels-such as SLT users, healthcare professional, policy advocates supplier, labeling, legal policies, and educating at various platforms. Effective strategies for the cessation of SLT is mandatory with proper guidance for the manufacturer, users and sellers in controlling SLT products.

No abstract

Tobacco use increases the risk of contracting tuberculosis (TB), and blights the response to treatment of the disease. Although Links between Tobacco and TB have long been suspected, still many Indian patients continue to use tobacco. Our goal is to couple reviews of older and new research to provide definitive evidence of this dangerous connection so as to put an end to the TB epidemic.: Search of studies with English language abstract published between 2000 to June 2020 was undertaken in Google Scholar and PubMed. Search included the use of keywords “tobacco” with “tuberculosis,” “cessation,” or ‘’Tuberculosis Control Programme’’. Reference lists of the articles were examined for other relevant titles that included effective estimates of tobacco exposure in relation to tuberculosis outcomes.: Available evidence shows a strong association between tobacco and tuberculosis. People who use tobacco unknowingly put themselves at high risk of getting this disease. Reduction in the prevalence of tobacco use is urgent to bring about collateral benefits in the control of the TB problem.It is high time that TB control programs must begin to address tobacco control. Within the healthcare system opportunities must be created to provide encouragement for the TB patients so that it is easier for them to overcome this addiction.There urgent need for research in the field of tobacco and tuberculosis so as to reduce the burden of tuberculosis in India.

Smokeless Tobacco [SLT], a non-combustible form of tobacco, is consumed by 350 million people in 133 countries across the globe. Worldwide, Smokeless Tobacco products vary greatly in their formulations and chemical composition. Understanding of toxic and carcinogenic constituent variations in such products can provide valuable insights for the development of effective tobacco control policies. Though the assessment of SLT products has been done earlier, the information is not available in an inclusive and handy format as entire profiling. Hence, there is a vital need to develop a one-stop information source providing comprehensive information on SLT products. PubMed and Google scholar databases were systematically searched from 1995 till April 2020 for observational studies on Smokeless Tobacco products and their chemical components. The included studies were evaluated and data were extracted and reviewed.A wide variation was noted in the association of various diseases and specific Smokeless Tobacco product constituents based on their nature and inherent toxicity. The majority of chewing tobacco products displayed a higher risk for users.This review emphasizes the significant positive association of Smokeless Tobacco product components with health hazards. Pathways estimates for smokeless tobacco-associated disease need further analysis. The profiling of Smokeless Tobacco products also requires multi-centric well-designed studies. Further, the information would be a guide for researchers interested in the components of SLT products.